For example, the acquisition of TP53 missense mutations in low-frequency sub-clones inside the primary tumor and their subsequent accumulation in metastasis samples may indicate that TP53 mutations increase the metastatic potential of tumor clones and are key drivers for PCa metastasis (74, 76). This evidence concerns the gene TP53 and posterior cortical atrophy.